The Community Assessment of Military Transitions study will be examining service member and military family experiences during the post-deployment transition.
Tjorvi Perry, MD, MMSc, Associate Professor, and Richard Prielipp, MD, MBA, Professor, were both featured on the list for the care they provide their patients.
The Department of Otolaryngology, Head and Neck Surgery boasts well-known faculty physicians in cleft palate and craniofacial surgery and care. As they study surgical outcomes, Brianne Roby, MD, and Robert Tibesar, MD, lean on the support of medical students and trainees to advance their academic research.
Nicholas Levinson, PhD, in the Department of Pharmacology, leads a laboratory using unique methods to better understand how protein kinases promote cancer cell growth and how to design more selective drugs to target and block their functions.
Christina Camell, PhD, assistant professor in the Department of Biochemistry, Molecular Biology and Biophysics, leads a study to uncover the role of immune cells in age-related metabolic dysfunction.
Led by Mustafa al’Absi, PhD, the Stress and Resilience Laboratories launched a global study to map out the behavioral and socioeconomic dynamics of how people have adjusted during the COVID-19 pandemic.
A new study from the University of Minnesota Medical School found that allopurinol, an inexpensive generic drug that reduces uric acid levels, did not show benefits in protecting from loss of filtering function in the kidney.
Medical School faculty members, Clark Chen, MD, PhD, Kathryn Dusenbery, MD, and Clara Ferreira, PhD, received the “Appreciation of Excellence” award for their commitment to treating brain cancer patients using innovative GammaTile Technology.
Mark R. Schleiss, MD, American Legion and Auxiliary Research Foundation Chair and professor in the Department of Pediatrics, will tap into saliva samples, originally collected from days-old infants to study CMV, to answer two questions—does mother-to-baby transmission of COVID-19 exist, and did the virus arrive in Minnesota earlier than March 2020?
Tourette Syndrome (TS) is a neurodevelopmental disorder, which is part of the spectrum of tic disorders and is characterized by motor and vocal tics. It is a relatively rare disorder that impacts around one percent of people and has varying degrees of impact on the quality of life of those affected. It often comes along with co-occurring emotional, behavioral and psychological difficulties that can add additional challenges to wellbeing and functioning. Unfortunately, right now there is no cure for TS, and the best treatments that exist only help around 50% of patients.